Report ID: SQSG35B2013
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Prefilled Syringes Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Prefilled Syringes industry players.
Prefilled syringes are a market with a high level of competition and intense price competition. Global and local businesses are present in the industry. Local businesses that sell prefilled syringes for less are common in poor nations. Global corporations, however, have a significant market share. Only a small number of businesses are anticipated to enter the market in the near future, but they are anticipated to hold a sizable portion of the prefilled syringes industry.
Prefilled Syringes Market Top Player's Company Profiles
REQUEST FOR SAMPLE
Global Prefilled Syringes Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.32 Billion in 2025 to USD 18.62 Billion by 2033, growing at a CAGR of 10.6% during the forecast period (2026–2033).
Key vendors in the Prefilled Syringes Market include Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT AG, Baxter International Inc., Cardinal Health, Terumo Corporation, West Pharmaceutical Services, Nipro Corporation, Ompi, SGD Pharma, Stevanato Group, Medtronic, Fresenius Kabi, and Ypsomed Holding AG.
The key driver of the Prefilled Syringes Market is the growing demand for convenient, accurate, and ready-to-use drug delivery systems, particularly for biologics and chronic disease treatments. Prefilled syringes reduce dosing errors, improve administration convenience, and support self-injection and home-based care.
The key market trend in the Prefilled Syringes Market is the increasing adoption of self-administration and home-based care, driven by demand for convenient, ready-to-use, ergonomic, and safety-enhanced drug delivery systems for chronic disease therapies.
North America accounted for the largest share at 32.3% in 2023, supported by advanced healthcare infrastructure, strong adoption of self-administered injection devices, needlestick injury prevention, technological advancements, and increasing demand for convenient drug delivery systems.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQSG35B2013
[email protected]
USA +1 351-333-4748